What Happened?
Boulder, CO-based Muse bio Appointed Kevin Ness as Chief Executive Officer
About the Company
Muse bio is transforming genome engineering by enabling, for the first time, high throughput massively-multiplexed CRISPR editing of proteins, pathways, and genomes. Through our powerful bioinformatics and novel molecular approach, ForgeCraft generates low-cost libraries of thousands of designer protein, pathway, or genome variants each with specifically defined, trackable mutations. This allows the impact of specific changes to be determined through rapid selection and high throughput screening allowing research timelines and costs to be reduced.
About the Person
Kevin Ness is Chief Executive Officer at Muse bio. Previously, Kevin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile